Perfusion Systems Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

  • Single User License $3500

Perfusion Systems Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 - 2025

Status : August, 2020 | Medical Devices | PPT format

Report Digest

Global Perfusion Systems Market: Overview

Perfusion refers to the passage of fluid, usually blood, through the circulatory or lymphatic system to a tissue or an organ. Since poor perfusion can cause some severe health problems such as deep vein thrombosis and coronary artery disease. It has been observed that during major surgeries, particularly cardiothoracic surgeries and organ transplant, maintenance of perfusion is paramount. Static cold storage (SCS) and machine perfusion (MP) are two frequently adopted preservation processes for high-risk organs, though in the recent times, hypothermic machine perfusion (HMP) has emerged as a reliable and effective solution to meet the desired results of perfusion. More than one hundred thousand perfusion procedures are performed each year worldwide. Consequently, the demand in the global perfusion systems market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

Global Perfusion Systems Market: Key Trends

Increasing incidences of chronic diseases, which often lead to the requirement of organ transplant, is the primary driver of the market for perfusion systems. In addition to that, cases of organ failure due to other factors such as improper diet, smoking and consumption of alcohol, and ignorance are consistently incrementing too, which has led to the demand of effective perfusion systems. As many as 661,000 people were reported for kidney failure in the U.S. alone, as per a recent estimations made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIH).

Transplantation is the only effective treatment for organ failure that reach end-stage. With technological advancements, the success rate of organ transplant has significantly increased, and augurs well for the future of the global perfusion systems market. On the other hand, lack of donors and government regulations against paid donations is the most prominent factor hindering the growth rate of the perfusion system market. As per the statistics released by the Center for Disease Control (CDC), 75,000 people had registered for organ donations while only 8,000 actual donations were available. High cost of these surgeries is another restraining factor for this market.

Based on technology, the global perfusion systems market can be segmented into normothermic and hypothermic. On the basis of organ-type, the market can be categorized into heart, lung, liver, kidney, and others.

Global Perfusion Systems Market: Market Potential

The advent of hypothermic machine perfusion is opening new possibilities for the stakeholders of this market. HMP already accounts for the maximum share of demand in the perfusion system market for its benefits such as proven alternative for cold storage of kidney preservation and helps in increasing patient’s survival rate during the transplant. Research and development is in full swing in order to check the feasibility of HMP for the transplantation of other organs such as liver, which may further increase the potential of this market in the near future.

Global Perfusion Systems Market: Regional Outlook

North America is the most lucrative region for the vendors operating in perfusion systems market due to increasing demand for organ transplant and cardiothoracic surgeries. Several government initiatives to raise the awareness for organ donation in the U.S. and Canada is expected to further increment the demand for perfusion systems in North America. Cost of these surgeries is hindering the expansion of the market in developing regions such as Asia Pacific.

Global Perfusion Systems Market: Competitive Landscape

Medtronic plc, Getinge AB, Lifeline Scientific, Inc., LivaNova PLC, XENIOS AG, XVIVO Perfusion AB, Spectrum Laboratories, Inc., Merck KGaA, Terumo Corporation, ALA Scientific Instruments, Repligen Corporation, and Harvard Bioscience, Inc. are some of the leading companies currently operating in the global perfusion systems market.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.